Discovery should separate symptoms from causes

A buyer often arrives with a visible symptom: slow sales, poor adoption, late projects or rising costs. The adviser is tempted to recognise a familiar pattern and move quickly to a solution. Speed can be useful, but premature certainty makes the engagement vulnerable.

Trace the symptom through a recent example. A late proposal might reflect unclear requirements, unavailable technical staff or an approval process with no owner. Those causes call for different interventions even though the visible delay is the same.

Ask what happens when the symptom is absent. Comparing a successful instance with a failed one can reveal a meaningful difference. It may also expose the limits of the buyer's initial explanation.

Avoid claiming that a short discovery call establishes causality. It usually produces a working diagnosis and a plan for further investigation. State what evidence would strengthen or weaken that diagnosis.

The distinction matters commercially. If you sell a remedy before understanding the cause, you may become responsible for an outcome your work cannot influence. A more careful diagnosis can narrow the promise and make the proposal easier to defend.

There is a balance to strike. Endless investigation can become avoidance. Gather enough evidence for the next decision, explain remaining uncertainty and agree how it will be resolved. The appropriate depth depends on the cost and reversibility of being wrong.